• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Eledon Pharmaceuticals, Inc. - Common Stock (NQ:ELDN)

    1.645 -0.005 (-0.30%)
    Streaming Delayed Price Updated: 10:17 AM EST, Jan 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 122,894
    Open 1.650
    Bid (Size) 1.640 (1,100)
    Ask (Size) 1.650 (1,100)
    Prev. Close 1.650
    Today's Range 1.630 - 1.665
    52wk Range 1.350 - 4.965
    Shares Outstanding 22,506,956
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Tuesday's after hours session: top gainers and losers ↗
    As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
    Via Chartmill

    Performance

    YTD
    +1.5%
    +1.5%
    1 Month
    +3.5%
    +3.5%
    3 Month
    -42.5%
    -42.5%
    6 Month
    -47.1%
    -47.1%
    1 Year
    -64.5%
    -64.5%

    More News

    Read More
    News headline image
    Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
    Via MarketMinute
    Topics Initial Public Offering Intellectual Property Regulatory Compliance
    News headline image
    Top movers in Wednesday's pre-market session ↗
    Via Chartmill
    News headline image
    Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
    Via MarketMinute
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study ↗
    Via Benzinga
    News headline image
    Dow Dips Over 200 Points; Fluor Shares Slide After Q3 Results ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Top movers in Friday's session ↗
    Via Chartmill
    News headline image
    Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
    From Eledon Pharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Eledon Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Eledon Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Eledon Pharmaceuticals, Inc. - Common Stock trade on?
    Eledon Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock is ELDN on the Nasdaq Stock Market
    What is the current price of Eledon Pharmaceuticals, Inc. - Common Stock?
    The current price of Eledon Pharmaceuticals, Inc. - Common Stock is 1.645
    When was Eledon Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Eledon Pharmaceuticals, Inc. - Common Stock was at 01/06/26 10:17 AM ET
    What is the market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock is 37.02M
    How many shares of Eledon Pharmaceuticals, Inc. - Common Stock are outstanding?
    Eledon Pharmaceuticals, Inc. - Common Stock has 37M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.